» Articles » PMID: 30791746

Changes in the Transcriptome of Circulating Immune Cells of a New Zealand Cohort with Myalgic Encephalomyelitis/chronic Fatigue Syndrome

Overview
Publisher Sage Publications
Date 2019 Feb 23
PMID 30791746
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a poorly understood disease affecting 0.2%-2% of the global population. To gain insight into the pathophysiology of ME/CFS in New Zealand, we examined the transcriptomes of peripheral blood mononuclear cells by RNA-seq analysis in a small well-characterized patient group (10 patients), with age/gender-matched healthy controls (10 control subjects). Twenty-seven gene transcripts were increased 1.5- to sixfold and six decreased three- to sixfold in the patient group ( P < 0.01). The top enhanced gene transcripts, IL8, NFΚBIA and TNFAIP3, are functionally related to inflammation, and significant changes were validated for IL8 and NFΚBIA by quantitative polymerase chain reaction (qPCR). Functional network analysis of the altered gene transcripts ( P < 0.01) detected interactions between the products related to inflammation, circadian clock function, metabolic dysregulation, cellular stress responses and mitochondrial function. Ingenuity pathway analysis ( P < 0.05) provided further insights into the dysfunctional physiology, highlighting stress and inflammation pathways. This analysis provides novel insights into the molecular changes in ME/CFS and contributes to the understanding of the pathophysiological mechanisms of the disease.

Citing Articles

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

Arron H, Marsh B, Kell D, Khan M, Jaeger B, Pretorius E Front Immunol. 2024; 15:1386607.

PMID: 38887284 PMC: 11180809. DOI: 10.3389/fimmu.2024.1386607.


IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry.

Fonseca A, Szysz M, Ly H, Cordeiro C, Sepulveda N Medicina (Kaunas). 2024; 60(1).

PMID: 38256421 PMC: 10820613. DOI: 10.3390/medicina60010161.


A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome.

Peppercorn K, Edgar C, Kleffmann T, Tate W Sci Rep. 2023; 13(1):22068.

PMID: 38086949 PMC: 10716514. DOI: 10.1038/s41598-023-49402-9.


Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project.

Gamer J, Van Booven D, Zarnowski O, Arango S, Elias M, Kurian A Int J Mol Sci. 2023; 24(12).

PMID: 37373402 PMC: 10299261. DOI: 10.3390/ijms241210255.


Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.

Tate W, Walker M, Peppercorn K, Blair A, Edgar C Int J Mol Sci. 2023; 24(6).

PMID: 36982194 PMC: 10048882. DOI: 10.3390/ijms24065124.


References
1.
Lorusso L, Mikhaylova S, Capelli E, Ferrari D, Ngonga G, Ricevuti G . Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2008; 8(4):287-91. DOI: 10.1016/j.autrev.2008.08.003. View

2.
Gow J, Hagan S, Herzyk P, Cannon C, Behan P, Chaudhuri A . A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics. 2009; 2:38. PMC: 2716361. DOI: 10.1186/1755-8794-2-38. View

3.
Zhang L, Gough J, Christmas D, Mattey D, Richards S, Main J . Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2009; 63(2):156-64. PMC: 2921262. DOI: 10.1136/jcp.2009.072561. View

4.
Naviaux R, Naviaux J, Li K, Bright A, Alaynick W, Wang L . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2016; 113(37):E5472-80. PMC: 5027464. DOI: 10.1073/pnas.1607571113. View

5.
Nguyen C, Alsoe L, Lindvall J, Sulheim D, Fagermoen E, Winger A . Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival. J Transl Med. 2017; 15(1):102. PMC: 5426002. DOI: 10.1186/s12967-017-1201-0. View